Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus versus prednisolone for minimal change disease nephrotic syndrome
2009-014292-52Phase 4Completed
- Sponsor
- Imperial College Healthcare NHS Trust
- Start
- Aug 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in nephrosis comparing Tacrolimus arm with Prednisolone arm (2 arms). Primary endpoint: Complete remission at 8 weeks. Started Aug 2010; status: completed.
02
Drugs
tacrolimusprednisolone
03
Conditions
nephrosis
Beyond the preview
Go deeper on 2009-014292-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014292-52.